Filing Flows › Rockwell Medical (RMTI) › Stock forecast & fair value
Rockwell Medical (RMTI) stock forecast and price target
Rockwell Medical (RMTI) trades at $7.73. The analysts' price target is $20.00 (+159%).
Rockwell Medical's latest quarter
Rockwell Medical, Q2 2026: revenue $17.8M (+11% year over year), operating margin -6.0%, net loss $1.2M, operating cash flow $2.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for RMTI stock?
The analysts' 12-month target is $20.00, +159% from $7.73. The average rating is none.
Does Rockwell Medical usually beat earnings estimates?
It beat the consensus EPS estimate in 0% of the quarters on record.
Is RMTI stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.